Volume 12, Issue 1 (Feb 2024)
Res Mol Med (RMM) 2024, 12(1): 0-0 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Tamizifar B, Rahimkhorasani M, Kassaian N, Adibi P, Sabzali S, Shahzamani K. Evaluating COVID-19 Vaccine Side Effects in Patients with Inflammatory Bowel Disease: A Case-Control Study in Iran. Res Mol Med (RMM) 2024; 12 (1)
URL: http://rmm.mazums.ac.ir/article-1-575-en.html
URL: http://rmm.mazums.ac.ir/article-1-575-en.html
Babak Tamizifar1 
, Marzieh Rahimkhorasani2 , Nazila Kassaian2 , Peyman Adibi2 , Somaieh Sabzali3 , Kiana Shahzamani4
, Marzieh Rahimkhorasani2 , Nazila Kassaian2 , Peyman Adibi2 , Somaieh Sabzali3 , Kiana Shahzamani4
1- Nosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, Iran , Babaktamizifar@gmail.com
2- Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
3- Department of Biology, Faculty of Basic Sciences, Lorestan University, Khorramabad, Iran
4- Hepatitis Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran
2- Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
3- Department of Biology, Faculty of Basic Sciences, Lorestan University, Khorramabad, Iran
4- Hepatitis Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
